Industry Voices News
Most Popular Industry Voices Story
Economics and politics: A lethal cocktail for pharma and biotech
Dr. David Gershon is the Chairman of the National Institute for Healthcare Economics and Regulatory Policy, is a designated Standard & Poor's 'Industry Leader,' and currently serves on the... Read more...
Latest Headlines
- February 11, 2009
- February 11, 2009
- January 13, 2009
- December 1, 2008
- November 17, 2008
- October 27, 2008
- September 30, 2008
- September 8, 2008
- August 11, 2008
- May 20, 2008
- May 1, 2008
- April 30, 2008
- April 22, 2008
- April 21, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
